Global Cancer Consortium Advances Precision Oncology Practice
The Global Cancer Consortium and 15th East Zonal Oncology Symposium (GCC-EZOS) convened leading scientists, clinicians, industry innovators, and policymakers in Kolkata for a two-day conference on precision oncology in 2026. Sessions highlighted genomics, biomarkers, AI in oncology, immunotherapy, targeted therapeutics, and translational research, plus pre-conference workshops on Cardio-Oncology and Cancer Genomics. Organizers emphasized translating innovations into clinical practice to accelerate personalized cancer diagnosis, treatment, and prevention.
Key Points
- 1Showcases genomics, biomarkers, AI, immunotherapy, targeted therapeutics, and translational research at GCC-EZOS 2026
- 2Highlights collaboration among global scientists, clinicians, industry and policymakers to accelerate precision oncology translation
- 3Enables practitioners to adopt genomics-guided therapies, AI tools, and translational workflows in clinical trials
Scoring Rationale
Conference-wide translational focus and credible international participation drive the score; lacks single novel peer-reviewed study or groundbreaking data.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems